C4PAIN ApS: Financial statements 2024
CVR: 32292402
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
C4PAIN ApS (CVR 32292402) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,257,321 and a net result of DKK 1,074,600 compared with DKK 96,580 the year before. That is an increase of 4,444.8% compared with the year before. Equity in the 2024 report amounted to DKK 3,978,856. The solvency ratio was 90.3%.
- Gross Profit
- DKK 1,257,321
- Profit/Loss
- DKK 1,074,600
- Equity
- DKK 3,978,856
- Total Assets
- DKK 4,405,082
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 1.3 mio. | 1.1 mio. | 4 mio. | - |
| 2023 | - | 28 t. | 97 t. | 2.9 mio. | - |
| 2022 | - | 252 t. | 237 t. | 2.8 mio. | - |
| 2021 | - | 53 t. | 70 t. | 2.6 mio. | - |
| 2020 | - | 658 t. | 542 t. | 2.5 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
C4PAIN ApS has published its annual report for 2023. Gross profit came to DKK 27,665, and the net result was DKK 96,580.
As of June 28, 2024, REDMARK, GODKENDT REVISIONSPARTNERSELSKAB has stepped down as auditor of C4PAIN ApS.
About C4PAIN ApS
C4PAIN ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2009. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lars Arendt-Nielsen. The company is owned by BIO-MEDICAL CONSULT HOLDING ApS. The company has 0 employees (2014). In 2025, the company reported a gross profit of DKK 159,243 and a net result of DKK 185,909 compared with DKK 1,074,600 the year before. Equity in the 2025 report amounted to DKK 4,164,765.